Latest News & Updates

Biologics Contribute to Growth in Pharma Products Cold-Chain Market

In its September issue, Pharmaceutical Commerce details the previous and expected contributions of biologic products to its forecast of cold-chain market growth predicting sales of cold-chain drugs and biologics will outpace overall industry growth through 2022. It is reported that “as of 2018, global...

Wednesday, September 12, 2018 | Read More

FDA Researchers Explore Fundamental Chemical Reaction that Could Threaten the Quality of Therapeutic Protein Products

In a recent news release the FDA described research it has conducted regarding detection of protein carbonylation, an oxidative reaction that may occur in therapeutic protein drug products during manufacture, storage, use, and transport potentially causing structural alterations and threatening stability,...

Tuesday, September 11, 2018 | Read More

Sentry representatives attend DCAT week

Sentry BioPharma Services is pleased to announce delegates from Sentry’s Business Development team will be in New York City attending the Drug, Chemical & Associated Technologies Association (DCAT) Week March 19th -22nd. The four-day conference brings together key sourcing, procurement and business...

Monday, March 19, 2018 | Read More

Leadership

John A. Warner - Executive Vice President / Interim Director of Quality Assurance, Regulatory Affairs

Mr. John A. Warner approaches his role at Sentry with over 30 years of experience in various areas in the pharmaceutical industry including consulting; hospital and clinical pharmacy management; clinical trial development, monitoring, and management; research and development including dosage formulation and production of clinical supplies; all aspects of regulatory affairs including preparation and submission of NDAs, ANDAs, 510(k)s, CE mark applications, qualified health claims, Orphan Drug requests, and meetings with FDA; quality systems and compliance; and executive management, including serving as the president of a medium sized pharmaceutical manufacturer.

Mr. Warner holds a J.D. from the University of Kentucky College of Law as well as an M.P.A. from Kentucky’s Martin School of Public Administration.  He also holds a B.S. in Biology from the University of Kentucky.